Rare Cancer News » Google - Rare CNS Tumor

Feeds

3156 items (3156 unread) in 87 feeds

• Google - Acinar Cell Carcinoma
• PubMed - Acinar Cell Carcinoma (27 unread)
• Trial - Acinar Cell Carcinoma

• Google - Acinic Cell Carcinoma
• PubMed - Acinic Cell Carcinoma (30 unread)
• Trial - Acinic Cell Carcinoma

• Google - Adenoid Cystic Carcinoma (8 unread)
• PubMed - Adenoid Cystic Carcinoma (51 unread)
• Trial - Adenoid Cystic Carcinoma (2 unread)

• Google - Adrenal Cancer (86 unread)
• Google - Adrenocortical Carcinoma (6 unread)
• PubMed - Adrenal Cancer (111 unread)
• PubMed - Adrenocortical Carcinoma (35 unread)
• Trial - Adrenal Cancer (2 unread)
• Trial - Adrenocortical Carcinoma (1 unread)

• Google - Ampullary Cancer
• PubMed - Ampullary Cancer (18 unread)
• Trial - Ampullary Carcinoma

• Google - Anal Cancer (87 unread)
• PubMed - Anal Cancer (124 unread)
• Trial - Anal Cancers (3 unread)

• Google - Angiosarcoma (10 unread)
• PubMed - Angiosarcoma (59 unread)
• Trial - Angiosarcoma (1 unread)

• Google - Appendix Cancer (6 unread)
• PubMed - Appendix Cancer (39 unread)
• Trial - Appendix Cancer

• Google - Bile Duct Cancer (75 unread)
• Google - Cholangiocarcinoma (33 unread)
• PubMed - Bile Duct Cancer (158 unread)
• PubMed - Cholangiocarcinoma (160 unread)
• Trial - Bile Duct Cancer (4 unread)
• Trial - Cholangiocarcinoma (2 unread)

• Google - Rare Brain Tumor (108 unread)
• Google - Rare CNS Tumor (12 unread)
• HemeOncLinx - Neurologic Oncology (27 unread)
• PubMed - Ganglioglioma (13 unread)
• PubMed - Rare Brain Tumor (169 unread)
• PubMed - Rare CNS Tumor (182 unread)
• Trial - Brain Tumor (35 unread)
• Trial - CNS Tumor (70 unread)
• Trial - Ganglioglioma

• Google - Carcinoid (30 unread)
• PubMed - Carcinoid (117 unread)
• Trials - Carcinoid (4 unread)

• Endocrine Oncology (11 unread)
• Google - Merkel Cell Cancer (64 unread)
• PubMed - Merkel Cell Cancer (38 unread)
• Trial - Merkel Cell Cancer
• Trial - Neuroendocrine Cancers (33 unread)

• Google - Gall Bladder Cancer (16 unread)
• PubMed - Gall Bladder Cancer (74 unread)
• Trials - Gall Bladder Cancer (2 unread)

• HemeOncLinx - Alternative Therapies (8 unread)

• Google - Hemangioendothelioma
• PubMed - Hemangioendothelioma (33 unread)
• Trial - Hemangioendothelioma

• Bone/Cartilage (11 unread)
• HemeOncLinx - Side Effects (10 unread)
• Hepatobiliary/Pancreas (17 unread)
• Pain/Palliative Care (12 unread)
• Pediatric Heme/Oncology (26 unread)

• Google - Hepatoblastoma (24 unread)
• PubMed - Hepatoblastoma (26 unread)
• Trial - Hepatoblastoma

• Google - Insulinoma (2 unread)
• PubMed - Insulinoma (68 unread)
• Trial - Insulinoma (1 unread)

• Google - Phyllodes Tumor (1 unread)
• PubMed - Phyllodes Tumor (24 unread)
• Trial - Phyllodes

• Google - Pseudomyxoma Peritonei (13 unread)
• PubMed - Pseudomyxoma Peritonei (PMP) (15 unread)
• Trial - Pseudomyxoma Peritonei

• Google - Rhabdomyosarcoma (42 unread)
• PubMed - Rhabdomyosarcoma (99 unread)
• Trial - Rhabdomyosarcoma (3 unread)

• Google - Sarcoma (76 unread)
• HemeOncLinx - Sarcoma (11 unread)
• PubMed - Sarcoma
• Trial - Sarcoma (17 unread)

• Twitter / Bruce_S (126 unread)
• Twitter / childrenscancer (78 unread)
• Twitter / LiftUpEllie (160 unread)
• Twitter / LivingBeyond (80 unread)
• Twitter / MDAndersonNews (27 unread)
• Twitter / vaginal_cancer (3 unread)

Google - Rare CNS Tumor (12 unread)

• 

  Rexahn Pharmaceuticals could have 3 blockbusters. Currently trades under $1 - FOXBusiness

  Posted: February 10th, 2010, 10:29am CST

  Rexahn Pharmaceuticals could have 3 blockbusters. Currently trades under $1 FOXBusiness Zoraxel for erectile dysfunction is a CNS-based sexual dysfunction drug that simultaneously enhances the levels of both serotonin and dopamine ... and more »

• 

  Rexahn Pharmaceuticals could have 3 blockbusters. Currently trades under $1 - Trading Markets (press release)

  Posted: February 10th, 2010, 8:15am CST

  Rexahn Pharmaceuticals could have 3 blockbusters. Currently trades under $1 Trading Markets (press release) Zoraxel for erectile dysfunction is a CNS-based sexual dysfunction drug that simultaneously enhances the levels of both serotonin and dopamine ... and more »

• 

  About this author: - Seeking Alpha (blog)

  Posted: February 10th, 2010, 7:36am CST

  About this author: Seeking Alpha (blog) Zoraxel for erectile dysfunction is a CNS-based sexual dysfunction drug that simultaneously enhances the levels of both serotonin and dopamine ... and more »

• 

  Full Text (HTML) - Science Magazine (subscription)

  Posted: February 4th, 2010, 12:05pm CST

  Full Text (HTML) Science Magazine (subscription) During inflammation, Ly-6C + monocytes give rise to monocyte-derived DCs, for example, tumor necrosis factor (TNF) and inducible nitric oxide synthase ...

• 

  YM BIOSCIENCES ANNOUNCES WORLD-CLASS ONCOLOGY EXPERTS TO US CLINICAL ... - Genetic Engineering News (press release)

  Posted: January 4th, 2010, 5:10am CST

  YM BIOSCIENCES ANNOUNCES WORLD-CLASS ONCOLOGY EXPERTS TO US CLINICAL ... Genetic Engineering News (press release) ... interests in neuro-oncology, IMRT, IGRT, radiosensitizers, radioprotectors, CNS tumors, lung cancer, pediatric radiation oncology, and advanced imaging. ... and more »

• 

  YM BIOSCIENCES ANNOUNCES WORLD-CLASS ONCOLOGY EXPERTS TO US CLINICAL ... - Stockhouse

  Posted: January 4th, 2010, 4:48am CST

  YM BIOSCIENCES ANNOUNCES WORLD-CLASS ONCOLOGY EXPERTS TO US CLINICAL ... Stockhouse ... interests in neuro-oncology, IMRT, IGRT, radiosensitizers, radioprotectors, CNS tumors, lung cancer, pediatric radiation oncology, and advanced imaging. ... and more »

• 

  YM BIOSCIENCES ANNOUNCES WORLD-CLASS ONCOLOGY EXPERTS TO US CLINICAL ... - RTT News (press release)

  Posted: January 4th, 2010, 4:48am CST

  YM BIOSCIENCES ANNOUNCES WORLD-CLASS ONCOLOGY EXPERTS TO US CLINICAL ... RTT News (press release) ... interests in neuro-oncology, IMRT, IGRT, radiosensitizers, radioprotectors, CNS tumors, lung cancer, pediatric radiation oncology, and advanced imaging. ... and more »

• 

  YM BIOSCIENCES ANNOUNCES WORLD-CLASS ONCOLOGY EXPERTS TO US CLINICAL ... - CNNMoney.com (press release)

  Posted: January 4th, 2010, 4:36am CST

  YM BIOSCIENCES ANNOUNCES WORLD-CLASS ONCOLOGY EXPERTS TO US CLINICAL ... CNNMoney.com (press release) ... interests in neuro-oncology, IMRT, IGRT, radiosensitizers, radioprotectors, CNS tumors, lung cancer, pediatric radiation oncology, and advanced imaging. ... and more »

• 

  YM BIOSCIENCES ANNOUNCES WORLD-CLASS ONCOLOGY EXPERTS TO US CLINICAL ... - SYS-CON Media (press release)

  Posted: January 4th, 2010, 4:33am CST

  YM BIOSCIENCES ANNOUNCES WORLD-CLASS ONCOLOGY EXPERTS TO US CLINICAL ... SYS-CON Media (press release) ... interests in neuro-oncology, IMRT, IGRT, radiosensitizers, radioprotectors, CNS tumors, lung cancer, pediatric radiation oncology, and advanced imaging. ... and more »

• 

  YM BIOSCIENCES ANNOUNCES WORLD-CLASS ONCOLOGY EXPERTS TO US CLINICAL ... - Earthtimes (press release)

  Posted: January 4th, 2010, 4:33am CST

  YM BIOSCIENCES ANNOUNCES WORLD-CLASS ONCOLOGY EXPERTS TO US CLINICAL ... Earthtimes (press release) ... interests in neuro-oncology, IMRT, IGRT, radiosensitizers, radioprotectors, CNS tumors, lung cancer, pediatric radiation oncology, and advanced imaging. ... and more »

• 

  YM BIOSCIENCES ANNOUNCES WORLD-CLASS ONCOLOGY EXPERTS TO US CLINICAL ... - Benzinga

  Posted: January 4th, 2010, 4:32am CST

  YM BIOSCIENCES ANNOUNCES WORLD-CLASS ONCOLOGY EXPERTS TO US CLINICAL ... Benzinga ... interests in neuro-oncology, IMRT, IGRT, radiosensitizers, radioprotectors, CNS tumors, lung cancer, pediatric radiation oncology, and advanced imaging. ... and more »

• 

  Minnesota family says prayers to Blessed Seelos cured teen's cancer - The Pilot

  Posted: December 4th, 2009, 4:07am CST

  The Pilot

  Minnesota family says prayers to Blessed Seelos cured teen's cancer The Pilot In March 2008, Joey was diagnosed with midline carcinoma after having a walnut-size tumor removed from his chest. "This kind of cancer is so rare that, ...

TOP Gregarius 0.6.1 Website: Rare-Cancer.org Last Update: Mon Feb 15 07:37:21 2010